Hypertension and vascular complications

Meredith, Dr. P. A., Glasgow, United Kingdom
Hypertension and the metabolic syndrome(Archiv)
30-Aug-08
Sierra de la, Prof. A., Barcelona, Spain
Treating hypertension in the metabolic syndrome – are all drugs the same?(Archiv)
30-Aug-08
Lewanczuk, Dr. R., Alberta, Canada
Reducing the CV risk by anti-hypertensive combination strategies(Archiv)
30-Aug-08
Backer De, MD G., Ghent, Belgium
The POWER study(Archiv)
04-Sep-07
Cockcroft, Prof. J.R., Cardiff, United Kingdom
Effects on control blood pressure and aortic pulse wave velocity. Comparison between Eprosartan and Atenolol – is it of clinical relevance?(Archiv)
04-Sep-07
Lueders, Prof. S., Cloppenburg, Germany
Stress-associated hypertension at the workplace – first results of the STARLET project(Archiv)
04-Sep-07
Hanon, MD O., Paris, France
The OSCAR trial – first results(Archiv)
04-Sep-07
Sierra de la, Prof. A., Barcelona, Spain
Welcome and Introduction(Archiv)
04-Sep-06
Ram, Prof. V., Dallas, United States
Angiotensin Blockade with Eprosartan: Vascular and Functional Implications(Archiv)
04-Sep-06
Shlyakhto, Prof. E., Saint Petersburg, Russia
Observational Study on Cognitive Function And SBP Reduction (OSCAR): Methodology and Appraisal(Archiv)
04-Sep-06
Backer De, MD G., Ghent, Belgium
An Attempt to Focus the Limited Resources for Prevention in the Patients at Highest Need(Archiv)
04-Sep-06
Rupp, Prof. H., Marburg, Germany
Risk Reduction by Preventing Stroke. Need for Blockade of Angiotensin II and Catecholamines?(Archiv)
04-Sep-06
Messerli, Prof. H., New York, United States
Stroke prevention: not all antihypertensive drugs are created equal(Archiv)
06-Sep-05
Diener, Prof. H.-C., Essen, Germany
Blood pressure control: stroke and stroke prevention(Archiv)
06-Sep-05
Lueders, Prof. S., Cloppenburg, Germany
Principal results of a prospective randomized controlled study: Morbidity and mortality after stroke – Eprosartan compared with nitrendipine for secondary prevention (MOSES)(Archiv)
06-Sep-05
Martinez, Prof. M., Valencia, Spain
Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation and microparticle formation in hypertension. Relevant to prevent stroke?(Archiv)
06-Sep-05